Navigation Links
Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
Date:11/2/2009

NEW BRUNSWICK, N.J., Nov. 2 /PRNewswire/ -- In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to augment our Life Sciences Group with Clearstone Central Laboratories and the deep expertise of the people there. We intend to maintain the integrity of the operational teams and continue to invest in strengthening the company's focus on exceptional client service. Combined with our renewed focus on the consistent delivery of high quality service, flexibility and responsiveness that private ownership allows, we look forward to expanding Clearstone's market reach."

Clearstone Central Laboratories, formerly MDS Pharma Services' Central Labs business, is among the largest private Global Central Laboratory companies solely focused on clinical research and cardiac services. Through a unique network of wholly owned CAP certified laboratories, Clearstone offers central laboratory services spanning the clinical development lifecycle. With strategically placed laboratories in the Americas, Europe and Asia, all are equivalently equipped and harmonized to provide consistent, dependable results across programs, study phases and geographies.

In addition, Clearstone leverages information technology tools aligned with value add project management principles for managing global clinical trials. Each of its laboratories utilizes the company's centralized APOLLO-CLPM(TM) (Central Laboratory Protocol Manager) enabling Clearstone project management teams with real-time visibility to component and test level data. Viq Pervaaz, Vice President of Global Project Management commented, "We facilitate our strong project management and data management teams with innovative technology solutions and an advanced web based protocol management system to meet the needs of our clients."

About Czura Thornton: Czura Thornton is a private investment group that was founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading CRO Chiltern (www.chiltern.com), has interests in the life sciences, international trade, property and automotive sectors. In particular Messrs Czura and Thornton have extensive international experience in the laboratory and CRO sectors. For further information see www.czurathornton.com.

About Clearstone Central Laboratories: Clearstone Central Laboratories offers clinical laboratory and cardiac services solutions spanning the globe with 600 people and 6 facilities in Paris, Hamburg, Toronto, New Jersey, *Beijing and Singapore.

For further information see www.clearstonelabs.com.

*The acquisition of the China business is pending subject to receipt of required Chinese governmental approvals.

SOURCE Clearstone Central Laboratories


'/>"/>
SOURCE Clearstone Central Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
2. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
5. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
6. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
7. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
8. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):